QUOTE AND NEWS
SeekingAlpha  Jul 21  Comment 
By Benjamin Livingston: NPS Pharmaceuticals (NASDAQ:NPSP) is a biopharmaceutical that focuses on developing best-in-class therapies for extremely rare diseases that would otherwise not garner much attention from other competitors. With this...
Market Intelligence Center  Jul 17  Comment 
NPS Pharmaceuticals Inc (NPSP) traded between $27.29 and $28.67 before closing at $28.33 Wednesday and presents some attractive trading opportunities today according to MarketIntelligenceCenter.com's patented algorithms. The computer program that...
Market Intelligence Center  Jul 16  Comment 
MarketIntelligenceCenter.com’s patented algorithms have chosen the Jan. '15 $27.00 call for a couple of hedged-trading ideas on NPS Pharmaceuticals Inc (NPSP). A traditional covered call on NPS Pharmaceuticals yields 13.83% (27.28% annualized,...
Market Intelligence Center  Jun 24  Comment 
After Monday’s trading in NPS Pharmaceuticals Inc (NPSP) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 12.03% or 29.09% (for comparison purposes only), while providing 16.83% downside protection....
Market Intelligence Center  Jun 20  Comment 
MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on NPS Pharmaceuticals Inc (NPSP). Look at the Aug. '14 $29.00 covered call for a net debit in the $27.66 area. This trade has a...
StreetInsider.com  Jun 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NPS+Pharmaceuticals%27+%28NPSP%29+FDA+Adivsory+Meeting+for+Natpara+Pushed+Back/9568774.html for the full story.
Market Intelligence Center  Jun 3  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with NPS Pharmaceuticals Inc (NPSP) that should provide a 4.87% return in just 74 days. Sell one Aug. '14 call at the $28.00 level for each 100...
StreetInsider.com  Jun 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NPS+Pharmaceuticals+%28NPSP%29+Says+it+Hasn%27t+Had+Talks+with+Shire+%28SHPG%29+/9545666.html for the full story.
TheStreet.com  Jun 2  Comment 
NEW YORK (TheStreet) -- NPS Pharmaceuticals  surged Monday amid reports that Shire would take over the biopharmaceutical company. Shire recently set up a $5 billion credit facility from multiple banks led by Citigroup  to finance its...
Benzinga  Jun 2  Comment 
Shares of NPS Pharmaceuticals (NASDAQ: NPSP) are up more than 20 percent in Monday's pre-market trading following a 13 percent jump last Friday. Rumors arose Friday that the British drugmaker Shire (NASDAQ: SHPG) is looking to acquire NPS for...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki